NervGen Pharma Corp.

OTCPK:NGEN.F Stock Report

Market Cap: US$110.4m

NervGen Pharma Management

Management criteria checks 2/4

NervGen Pharma's CEO is Mike Kelly, appointed in Apr 2023, has a tenure of 1.08 years. directly owns 0.21% of the company’s shares, worth $227.31K. The average tenure of the management team and the board of directors is 3 years and 3.5 years respectively.

Key information

Mike Kelly

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.1yrs
CEO ownership0.2%
Management average tenure3yrs
Board average tenure3.5yrs

Recent management updates

Recent updates


CEO

Mike Kelly (57 yo)

1.1yrs

Tenure

Mr. Michael Kelly, also known as Mike, is an Independent Director of ARS Pharmaceuticals, Inc. and joined in May 2019. He serves as Chief Executive Officer, President and Director of NervGen Pharma Corp. s...


Leadership Team

NamePositionTenureCompensationOwnership
William Radvak
Co-Founder & Chairman7.3yrsCA$226.59k2.01%
CA$ 2.2m
Harold Punnett
Co-Founder & Independent Directorno datano data1.61%
CA$ 1.8m
William Adams
CFO & Corporate Secretary4.3yrsCA$378.05k0.22%
CA$ 246.0k
Daniel Mikol
Chief Medical Officer3yrsCA$635.63kno data
Michael Kelly
CEO, President & Director1.1yrsno data0.21%
CA$ 227.3k
Brian McAlister
Co-Founder & Advisorno datano datano data

3.0yrs

Average Tenure

60yo

Average Age

Experienced Management: NGEN.F's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
William Radvak
Co-Founder & Chairman7.3yrsCA$226.59k2.01%
CA$ 2.2m
Harold Punnett
Co-Founder & Independent Director7.3yrsno data1.61%
CA$ 1.8m
Michael Kelly
CEO, President & Director1.1yrsno data0.21%
CA$ 227.3k
Brian McAlister
Co-Founder & Advisorno datano datano data
Glenn Ives
Independent Director2.7yrsno data0.084%
CA$ 92.4k
Brian Bayley
Independent Director6yrsno data0.57%
CA$ 631.6k
Randall Kaye
Independent Director3.6yrsno data0.014%
CA$ 15.8k
Jeffrey Cummings
Member of Alzheimer's Disease Scientific Advisory Board3.3yrsno datano data
Jerry Silver
Co-Inventor & Scientific Advisorno datano datano data
George Perry
Member of Alzheimer's Disease Scientific Advisory Board3.3yrsno datano data
Henrik Zetterberg
Member of Alzheimer's Disease Scientific Advisory Board3.3yrsno datano data
Michael Davis
Advisor3.6yrsno datano data

3.5yrs

Average Tenure

61yo

Average Age

Experienced Board: NGEN.F's board of directors are considered experienced (3.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.